PCN42 COST ANALYSIS OF SEPSIS MANAGEMENT AFTER MYELOSUPPRESSIV CHEMOTHERAPY IN NSCLC AND LYMPHPOMA PATIENTS- A GERMAN HOSPITAL PERSPECTIVE
Abstract
Authors
B Paessens K Berger A Ihbe-Hefflnger C Mueller-Thomas M Shlaen C Von Schilling R Bernard C Peschel W Schramm